Ramipril Dosing for Hypertension and Heart Failure

Evidence for Cardiovascular Protection

In high-risk patients, ramipril 10 mg daily reduced the risk of myocardial infarction, stroke, or cardiovascular death by 22% over 5 years, according to the American College of Cardiology and other guideline societies 1, 2, 3
The target blood pressure is less than 130/80 mmHg for patients with stable ischemic heart disease and hypertension, as recommended by the American College of Cardiology and other guideline societies 1, 2, 3

Check serum potassium and creatinine after 5-7 days of starting therapy, and recheck every 5-7 days during titration until values are stable, as recommended by clinical guidelines 4
Monitor blood pressure, renal function, and electrolytes 1-2 weeks after each dose increment, and follow-up at 3 months, then every 6 months thereafter, according to clinical guidelines 4
A creatinine increase up to 50% above baseline, or to 3 mg/dL (whichever is greater) is considered an acceptable change, as stated in clinical guidelines 4
Avoid NSAIDs and COX-2 inhibitors as they worsen renal function and reduce ACE inhibitor efficacy, and avoid potassium-sparing diuretics during initiation unless specifically needed for persistent hypokalemia, as recommended by clinical guidelines 4

Higher doses of ramipril, such as 10 mg daily, provide superior outcomes in cardiovascular protection trials, showing significant mortality reduction, according to the American College of Cardiology and other guideline societies 1, 2, 3
In heart failure, higher ACE inhibitor doses reduce hospitalizations by 24% compared to low doses, as stated in clinical guidelines 4